Introduction
Ovarian cancer, the leading cause of death from gynecologic cancers, is seriously imperiling the health of women. The majority of women have already in an advanced stage while diagnosing because the signs and symptoms of ovarian cancer are frequently absent early on and when they exist they may be subtle (Goff et al., 2000) , and would be easily confused with other illnesses (Johannes, 2010) , making prognosis poor. This has led to problem that the 5-year relative survival rate is less than 30% in advanced-stage disease (Jemal et al., 2009 ). Fortunately, 5-year relative survival rate would increase to approximately 90% at an early stage (Clarke, 2009) , and furthermore, early detection will have no effect on fertility. Therefore, early detection of ovarian cancer plays an important role in successful treatment. Now, bimanual pelvic examination, cancer antigen (CA) 125, and transvaginal ultrasound are the main methods for early ovarian cancer detection (Jelovac et al., 2011) . However, they suffer the disadvantages of generally lacking sensitivity and specificity and being expensive. Therefore, a novel and cost-effective method with high sensitivity and specificity for ovarian cancer detection which we are currently investigating is urgently needed. Quartz crystal microbalance (QCM) immunosensor is an ultra-sensitive mass biosensor at the nanogram level. The core of the QCM immunosensor is the piezoelectric AT-cut quartz crystal sandwiched between a pair of electrodes. In QCM immunosensor, the target molecule was recognized by its homologous antibodies/antigens which are immobilized on the surface of a piezoelectric crystal. The resulting very small mass change is then transformed into the change in frequency of crystal resonator which is an easy measurable quantity. Here, the QCM immunosensor was used to evaluate the antibody content of the NuTu-19 cell in serum samples obtained from immunized New Zealand white rabbit. The frequency caused by specific adsorption on the surface of crystal significantly changed and can be easily measured by a frequency counter. The adsorption schematic is shown in Figure 1 . In addition, we employed the negative control to verify that the research has significance for early ovarian cancer detection.
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Materials and Methods
Animals and Cell line
New Zealand white rabbit were purchased from the West China Experimental Animal Center (Chengdu, China). NuTu-19, a rat ovarian cancer cell line were purchased from American Type Culture Collection (Manassas, VA, USA) and cultured according to the supplier's protocols. Cells were cultured onto the crystal surface in Dulbecco's modified Eagle medium (DMEM) (Gibco BRL, Grand Island, N.Y.) supplemented with 10% fetal bovine serum (Gibco BRL, Grand Island, N.Y.) and 100 ug/ml Amikacin. Cells were maintained in humidified chamber at 37 °C in 5% CO 2 atmosphere.
Animal inoculations and antibody preparation
New Zealand white rabbits were immunized with 1×10
7 NuTu-19 cells in complete Freund's adjuvant (CFA) (Sigma) at day 0 and followed by two boosts with 1×10
7 NuTu-19 cells in incomplete Freund's adjuvant (IFA) (Sigma) at day 14 and 28. To get the antibody of NuTu-19, rabbit heart blood were collected under light anesthesia a week after the last injection. Then serum IgG was separated using a protein separation column, and non-immune rabbit serum was used as a negative control.
Equipment and apparatus
The 3rd overtone AT-cut QCM quartz crystals (10MHz, optically polished surface, 5 mm gold electrodes on both sides) were obtained from Tangshan JingYuan YuFeng Electronics co., Ltd (Hebei, China). A high resolution frequency counter (Agilent 53131A) from Agilent Technologies (US) was employed to monitor the oscillation frequency. A self-made gate crystal oscillator with a 74HC04 integrated chip and 4.5 v dc power supply was used. A 0.1 ul-5 ul variable volume micropipette obtained from KeXiao co., Ltd (Hang Zhou, China) was used for better volume control of the liquids. The test diagram is shown in Figure 2 .
The relationship between the change in mass on the crystal surface and the corresponding change in the oscillation frequency has been shown by the well-known Sauerbrey equation as follows (Sauerbrey, 1959; Hlavay et al., 1977; Granstaff et al., 1994) : rF = -2.26 × 10 -6 nF 0 2 rm/A (1) where rm is the changed mass on the crystal surface, in g, rF is the change in resonance frequency of the coated crystal, in Hz, F 0 is the fundamental resonance frequency of the crystal, in Hz, n is the overtone number; A is the area of electrode surface, in cm 2 .The mass sensitivity of the quartz crystal used in this study is 0.376 Hz/ng.
Measurement procedure
The resonance frequency F 1 of all uncoated crystals were first measured by frequency counter at 25 ℃.After culturing NuTu-19 cells on the crystal surface, the crystal was dipped in 2% paraformaldehydy-phosphate buffered solution for 10 min, then washed with phosphate buffer solution (PBS, PH 7.4) and deionized water (DW) twice to wash away all interfering substances and dried in air at 25 ℃. Then the frequency F 2 of crystals with coated cells was subsequently counted. At last, the gold electrode surfaces of crystals were covered with NuTu-19-associated serum by micropipette and kept at 25 ℃ for 2 min, then washed with PBS and DW and air-dried, counting frequency F 3 . The serum free anti-NuTu-19 IgG was measured under the same condition as reference.
Results
Cell immobilization efficiency
The immobilization of antigen on the surface of quartz crystal plays an important role not only in detecting accuracy and specificity but also in shortening the reaction time. In this study, the NuTu-19 ovarian cancer cells were separately cultured on twenty crystals so as to make NuTu-19 antigens firmly immobilize on the crystal surface. Figure 3 shows the effect of varying the mass of the NuTu-19 cells on the electrode surface of quartz crystal. Since the added mass of cells did not exceed the load limit of the crystal (0.0048 g), the added mass of NuTu-19 cells is linearly proportional to the frequency changes of the quartz crystal. Therefore, the immobilization range for NuTu-19 cell was 0.22-1.14 ug. Figure 4 shows the frequency stability of the QCM during the test. Since the stability of QCM is a key factor to influence the detection accuracy, the QCM was placed in a thermostatic chamber at 25 ℃ to prevent the frequency stability from affecting by ambient temperature fluctuations and all the measurement equipments were started for 5 min in advance so as to make the equipments stable enough. The 3 rd overtone AT-cut model of QCM is of excellent accuracy with ±1 Hz at 25 ℃, and the results were highly reproducible.
Stability of QCM
Specificity and sensitivity of QCM
After culturing NuTu-19 cell on the surface of the 
Figure 4. Example of Measured Frequency Stability
quartz crystal, the frequency shifts increased sharply from 83 to 429 Hz, corresponding to the mass change of 0.22 and 1.14 ug, respectively. When added 1ul immunized serum droplet onto the centre of the crystal electrode surface, the frequency shifts (rF 1 ) increased significantly from 71 to 197 Hz, however, no significant changes in frequency shifts were observed when added on the same amount of the non-immune rabbit serum.
QCM immunosensor detection of the antibody of NuTu-19 from crude serum of immunized New Zealand white rabbit
QCM immunosensors exhibited significant increase in frequency shifts upon addition of crude serum containing the target antibody when compared with the negative control group. The frequency response to anti-NuTu-19 serum samples (rF 2 ) and negative control group (rF 3 ) were measured. The results were shown in Table 1 . Since other interference factors may have a slight influence on frequency shifts, the frequency shifts which were below 5 Hz measured in the negative control group can be approximately equal to 0 Hz in the experiment. So there were eight out of ten crystals exhibited significant increase in frequency shifts. The average mass change in the experiment was 341 ng. This obtained mass calculated from Sauerbrey equation using rF 2 was very close to the actual amount of mass (370 ng) added on the electrode of the crystal which was obtained using the protein quantification method.
In order to investigate the amount of frequency drop with respect to the added immunized serum droplet, the volume of serum added was from 0.2 µl to 1 µl, each time with a 0.2 µl serum droplet increase. The average of four measurements was shown in Table 2 .
Discussion
In this paper, a novel method for indirect rapid detection of early ovarian cancer was proposed. From the meaningful results discussed above, it is clear that the difference between the serum samples with the antibody of NuTu-19 and without the antibody of NuTu-19 is so obvious that QCM immunosensor can be used to detect the antibody content of NuTu-19 from immunized serum. The novel antigen immobilization method not only eliminated non-specific adsorption but also shortened the response time since low sensitivity may be got when delayed the response time (König & Grätzel, 1993; Babacan et al., 2009) . The 3rd overtone AT-cut model of QCM immunosensor used in this study increased the oscillation stability, ensuring the stability of whole test system. Furthermore, the sensitivity of this detection method was also ensured by this resonator. Although a difference between the obtained mass calculated from Sauerbrey equation and the actual amount of mass was existed, this work holds good for the quantitative detection of Nutu-19 in serum sample of ovarian cancer rabbits.
Besides high sensitivity and specificity, the proposed method in this study provides potential advantages, such as short analyzing time (less than 2 min), low cost (the heart of this detection system costs less than 1 dollar), and security (will not cause radiation damage for patients). Our study demonstrated that this novel detection method has no false-positive problem that it is particularly suited for health screening for the general population. This technique provides a viable alternative to early ovarian cancer detection methods. It also paves the way for its potential applicability in clinical practice. The only flaw that it can not identify the specific ovarian cancerassociated antibodies in serum samples makes our further investigation will focus on identifying the specific ovarian cancer-associated antibodies in serum.
